ARCHIVES

Bill Clinton Endorses NBCC’s 2020 Goal

This article is from The Cancer Letter archive.

Vol. 37 No. 02 | January 14, 2011

Download PDF Visit The Full Archive

Related Articles

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

February 25, 2011

In Brief: LEO Sachs To Receive 1983 Bristol-Myers Award; 50 Percent Current Rate Achievable Now: Tylor

April 1, 1983

In Brief: ACOS Moves Up Schedule for TNM Staging System From 1986 To “As Expeditiously As Possible”

January 13, 1984

Agents Not Indicated In Curative Setting.

August 8, 2008

Zinder Report Implementation, Surgical Conference, On NCAB Meeting June 17-18

May 31, 1974